[HTML][HTML] COVID-19 and preexisting comorbidities: risks, synergies, and clinical outcomes

B Bigdelou, MR Sepand, S Najafikhoshnoo… - Frontiers in …, 2022 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated
symptoms, named coronavirus disease 2019 (COVID-19), have rapidly spread worldwide …

Physical activity and COVID-19. The basis for an efficient intervention in times of COVID-19 pandemic

VJ Clemente-Suárez, AI Beltrán-Velasco… - Physiology & …, 2022 - Elsevier
Abstract The Coronavirus Disease 2019 (COVID-19) pandemic has shocked world health
authorities generating a global health crisis. The present study aimed to analyze the different …

[HTML][HTML] COVID-19 and the endocrine system: a comprehensive review on the theme

G Lisco, A De Tullio, A Stragapede… - Journal of clinical …, 2021 - mdpi.com
Background and aim. The review aimed to summarize advances in the topic of endocrine
diseases and coronavirus disease 2019 (COVID-19). Methods. Scientific and institutional …

[HTML][HTML] Evolution of SARS-CoV-2 variants: implications on immune escape, vaccination, therapeutic and diagnostic strategies

NZ Zabidi, HL Liew, IA Farouk, A Puniyamurti, AJW Yip… - Viruses, 2023 - mdpi.com
The COVID-19 pandemic caused by SARS-CoV-2 is associated with a lower fatality rate
than its SARS and MERS counterparts. However, the rapid evolution of SARS-CoV-2 has …

European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology …

Task Force for the management of COVID … - Cardiovascular …, 2022 - academic.oup.com
Aims Since its emergence in early 2020, the novel severe acute respiratory syndrome
coronavirus 2 causing coronavirus disease 2019 (COVID-19) has reached pandemic levels …

Comorbidities, associated diseases, and risk assessment in COVID‐19—a systematic review

A Fitero, SG Bungau, DM Tit, L Endres… - … Journal of Clinical …, 2022 - Wiley Online Library
It is considered that COVID‐19's pandemic expansion is responsible for the particular
increase in deaths, especially among the population with comorbidities. The health system …

European Society of Cardiology guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 1—epidemiology …

European Heart Journal, 2022 - academic.oup.com
Aims Since its emergence in early 2020, the novel severe acute respiratory syndrome
coronavirus 2 causing coronavirus disease 2019 (COVID-19) has reached pandemic levels …

[HTML][HTML] Modification of subcutaneous white adipose tissue inflammation by omega-3 fatty acids is limited in human obesity-a double blind, randomised clinical trial

HL Fisk, CE Childs, EA Miles, R Ayres, PS Noakes… - …, 2022 - thelancet.com
Background Obesity is associated with enhanced inflammation. However, investigation in
human subcutaneous white adipose tissue (scWAT) is limited and the mechanisms by which …

[HTML][HTML] Long-term exposure to PM10 above WHO guidelines exacerbates COVID-19 severity and mortality

M Marquès, E Correig, D Ibarretxe, E Anoro… - Environment …, 2022 - Elsevier
Background Age, sex, race and comorbidities are insufficient to explain why some
individuals remain asymptomatic after SARS-CoV-2 infection, while others die. In this sense …

Common bean (Phaseolus vulgaris L.) α‐amylase inhibitors as safe nutraceutical strategy against diabetes and obesity: An update review

S Peddio, A Padiglia, FB Cannea, R Crnjar… - Phytotherapy …, 2022 - Wiley Online Library
Overweight and obesity are constantly increasing, not only in Western countries but also in
low‐middle‐income ones. The decrease of both the intake of carbohydrates and their …